SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon has informed that the 45th AGM of the Company was held on Friday, August 11, 2023 through video conferencing, to transact the businesses as stated in the Annual General Meeting Notice dated May 23, 2023 and Addendum to the Notice dated July 26, 2023. In this regard, please find attached the following: Voting results pursuant to Regulation 44(3) of SEBI Listing Regulations (Annexure-1); Scrutinizer’s Report pursuant to Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 (Annexure-2); The voting results along with Scrutinizer’s Report are also made available on the Company’s website at www.biocon.com and also on the website of Registrar and Share Transfer Agents (RTA) of the Company at www.Kfintech.com

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

380.55 -2.05 (-0.54%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×